Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients-Reference-Cited by-同舟云学术

Mammalian Target of Rapamycin Inhibitors and Clinical Outcomes in Adult Kidney Transplant Recipients

Published:2016-07-21 Issue:10 Volume:11 Page:1845-1855
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Badve Sunil V.,Pascoe Elaine M.,Burke Michael,Clayton Philip A.,Campbell Scott B.,Hawley Carmel M.,Lim Wai H.,McDonald Stephen P.,Wong Germaine,Johnson David W.

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference21 articles.

1. A Systematic Review of Conversion From Calcineurin Inhibitor to Mammalian Target of Rapamycin Inhibitors for Maintenance Immunosuppression in Kidney Transplant Recipients

2. Conversion From Calcineurin Inhibitors to Sirolimus for Chronic Renal Allograft Dysfunction: A Systematic Review of the Evidence

3. Risk of Metabolic Complications in Kidney Transplantation After Conversion to mTOR Inhibitor: A Systematic Review and Meta-Analysis

4. Target of Rapamycin Inhibitors (Sirolimus and Everolimus) for Primary Immunosuppression of Kidney Transplant Recipients: A Systematic Review and Meta-Analysis of Randomized Trials

5. Everolimus leads to a lower risk of BKV viremia than mycophenolic acid inde novorenal transplantation patients: a single-center experience

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Kidney Transplant Cancer: A Real-World Retrospective Analysis From a Single Italian Center;Transplant International;2024-08-20

2. Long-Term Outcome after Early Mammalian Target of Rapamycin Inhibitor-Based Immunosuppression in Kidney Transplant Recipients;Journal of Clinical Medicine;2024-07-23

3. Cancer after kidney transplantation;Vnitřní lékařství;2023-10-26

4. Multiorgan Transplantation: Heart–Kidney;Textbook of Transplantation and Mechanical Support for End‐Stage Heart and Lung Disease;2023-09-08

5. Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation: A Scientific Statement From the American Heart Association;Circulation;2023-08-15